Travere Therapeutics TVTX
NASDAQ TVTX
$56.88 +0.03 (+0.05%)
As of: Oct 2, 2026 · 11:02 AM EDT

Travere Therapeutics (TVTX) Return on Equity [ROE] (2015 - 2026)

Updated

Travere Therapeutics' Return on Equity [ROE] was -70.53% in Q2 2026, up 445.25 percentage points from -515.78% a year earlier but down 50.47 percentage points from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Travere Therapeutics came in at -29.38%, up 218.07 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +48.99 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -247.45% in FY2024 (-156.01 pp), -91.44% in FY2023 (+70.02 pp), -161.46% in FY2022 (-91.29 pp) and -70.17% in FY2021 (+8.20 pp).
  • Quarterly Return on Equity [ROE] has moved between -2247.05% (Q4 2024) and -20.06% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of +62.16 percentage points over the last six quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 2219.93 percentage points); the worst was Q4 2024 (a drop of 2200.69 percentage points).
  • Per Business Quant data, TVTX's Return on Equity [ROE] in the three quarters before Q2 2026 was -20.06% (Q1 2026), -27.12% (Q4 2025) and -166.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Travere Therapeutics 5.55 Bn 5.14 Bn 167.41 Mn -70.53%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -70.53%
Mar 31, 2026 -20.06%
Dec 31, 2025 -27.12%
Sep 30, 2025 -166.57%
Jun 30, 2025 -515.78%
Mar 31, 2025 -493.47%
Dec 31, 2024 -2,247.05%
Jun 30, 2024 -327.08%
Mar 31, 2024 -117.24%
Dec 31, 2023 -46.36%
Sep 30, 2023 -43.94%
Jun 30, 2023 -201.19%
Mar 31, 2023 -249.01%
Dec 31, 2022 -388.06%
Sep 30, 2022 -234.22%
Jun 30, 2022 -146.59%
Mar 31, 2022 -93.83%
Dec 31, 2021 -71.30%
Sep 30, 2021 -78.21%
Jun 30, 2021 -68.22%
API Access

Travere Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY